Kodiak Sciences holder reports 5.2% stake

T. Rowe Price Associates, Inc. reports beneficial ownership of 3,248,611 shares of Kodiak Sciences Inc. common stock, representing 5.2% of the class.

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. reports beneficial ownership of 3,248,611 shares of Kodiak Sciences Inc. common stock, representing 5.2% of the class. It holds sole voting power over 3,247,060 shares and sole dispositive power over 3,248,611 shares, with no shared voting or dispositive power.

The reporting person states that this report should not be construed as an admission that it is the beneficial owner of these securities and expressly denies such beneficial ownership.

Key Figures

Shares beneficially owned: 3,248,611 shares Percent of class: 5.2% Sole voting power: 3,247,060 shares +3 more

6 metrics

Shares beneficially owned 3,248,611 shares Beneficial ownership of Kodiak Sciences common stock reported by T. Rowe Price Associates, Inc.

Percent of class 5.2% Percentage of Kodiak Sciences common stock class beneficially owned

Sole voting power 3,247,060 shares Shares over which T. Rowe Price Associates, Inc. has sole power to vote

Shared voting power 0 shares Shares over which T. Rowe Price Associates, Inc. has shared power to vote

Sole dispositive power 3,248,611 shares Shares over which T. Rowe Price Associates, Inc. has sole power to dispose

Shared dispositive power 0 shares Shares over which T. Rowe Price Associates, Inc. has shared power to dispose

Key Terms

beneficially owned, sole voting power, sole dispositive power, percent of class, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 3248611"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole power to vote or to direct the vote: 3247060"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole power to dispose or to direct the disposition of: 3248611"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

percent of class financial

"Percent of class: 5.2 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Schedule 13G regulatory

"form_type: "SCHEDULE 13G""

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does T. Rowe Price Associates report in Kodiak Sciences (KOD)?

T. Rowe Price Associates reports beneficial ownership of 3,248,611 shares of Kodiak Sciences common stock, representing 5.2% of the class, based on its Schedule 13G beneficial ownership disclosure.

How many Kodiak Sciences (KOD) shares can T. Rowe Price vote?

T. Rowe Price Associates reports sole voting power over 3,247,060 shares of Kodiak Sciences and no shared voting power, according to its Schedule 13G ownership disclosure.

What dispositive power does T. Rowe Price have over Kodiak Sciences (KOD) shares?

T. Rowe Price Associates reports sole dispositive power over 3,248,611 shares of Kodiak Sciences common stock and no shared dispositive power, meaning it alone can direct the disposition of those reported shares.

Does T. Rowe Price admit beneficial ownership of Kodiak Sciences (KOD) shares?

No. T. Rowe Price Associates states that the filing should not be construed as an admission that it is the beneficial owner of the reported securities and that such beneficial ownership is expressly denied.

What class of Kodiak Sciences (KOD) securities is held by T. Rowe Price?

The reported holdings by T. Rowe Price Associates are in Kodiak Sciences’ common stock, identified by CUSIP 50015M109, as disclosed in the Schedule 13G ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 10:38 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

KODIAK SCIENCES INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

50015M109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 50015M109

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,247,060.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,248,611.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,248,611.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KODIAK SCIENCES INC
(b)	Address of issuer's principal executive offices: 1250 PAGE MILL RD, PALO ALTO, CA, 94304
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP Number(s): 50015M109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3248611
(b)	Percent of class: 5.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3247060
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3248611
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	08/14/2026